Felig P, Wahren J, Hendler R, Brundin T
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
J Clin Invest. 1974 Feb;53(2):582-90. doi: 10.1172/JCI107593.
Arterial concentrations and splanchnic exchange of glucose, lactate, pyruvate, glycerol, free fatty acids, and individual acidic and neutral amino acids were determined in obese and nonobese control subjects in the basal state and during a 45 min infusion of glucose. Glucose was administered to the controls at a rate (2 mg/kg/min; 144 +/- 4 mg/min) known to inhibit splanchnic glucose output without influencing peripheral glucose utilization. The obese subjects received glucose at two dose levels (75 and 150 mg/min) which simulated either the rise in insulin or the inhibition in splanchnic glucose production observed in the controls. In the basal state splanchnic glucose production did not differ significantly between obese and control subjects. However splanchnic uptake of lactate, glycerol, alanine, free fatty acids, and oxygen was 50-160% greater in obese subjects. Splanchnic uptake of glucose precursors could account for 33% of hepatic glucose output in the obese group as compared to 19% in controls. The increase in alanine and lactate uptake was due in part, to a 50% increase in splanchnic fractional extraction. Administration of glucose to the control subjects 144 +/- 4 mg/min) resulted in a 50-60% increment in arterial insulin and a 75% reduction in splanchnic glucose output. In the obese group, infusion of glucose at a rate of 75 mg/min resulted in an equivalent rise in arterial insulin, but was accompanied by a less than 40% inhibition in splanchnic glucose output. Glucose infusion at a rate of 150 mg/min in the obese resulted in a 75% reduction in splanchnic glucose output which was equivalent to that observed in controls, but was accompanied by a significantly greater rise (100-200%) in arterial insulin. It is concluded that in obesity (a) despite basal hyperinsulinemia, splanchnic uptake of glucose precursors is increased, the relative contribution to total glucose release attributable to gluconeogenesis being 70% higher than in controls; (b) infusion of glucose at rates causing equivalent increases in arterial insulin induces a smaller inhibition in splanchnic glucose output than in controls; (c) infusion of glucose at rates causing comparable inhibition in splanchnic glucose output is accompanied by a disproportionately greater increase in endogenous insulin than in controls. These data are compatible with hepatic resistance to insulin in obesity.
在基础状态以及葡萄糖输注45分钟期间,测定了肥胖和非肥胖对照受试者体内葡萄糖、乳酸、丙酮酸、甘油、游离脂肪酸以及单个酸性和中性氨基酸的动脉浓度和内脏交换情况。以已知能抑制内脏葡萄糖输出而不影响外周葡萄糖利用的速率(2mg/kg/min;144±4mg/min)向对照受试者输注葡萄糖。肥胖受试者接受两种剂量水平(75和150mg/min)的葡萄糖,这模拟了对照受试者中观察到的胰岛素升高或内脏葡萄糖生成抑制情况。在基础状态下,肥胖和对照受试者的内脏葡萄糖生成没有显著差异。然而,肥胖受试者的内脏对乳酸、甘油、丙氨酸、游离脂肪酸和氧气的摄取量要高出50%-160%。肥胖组中,内脏对葡萄糖前体的摄取量可占肝脏葡萄糖输出的33%,而对照组为19%。丙氨酸和乳酸摄取量的增加部分归因于内脏分数提取增加了50%。向对照受试者输注葡萄糖(144±4mg/min)导致动脉胰岛素增加50%-60%,内脏葡萄糖输出减少75%。在肥胖组中,以75mg/min的速率输注葡萄糖导致动脉胰岛素等量升高,但内脏葡萄糖输出的抑制率不到40%。肥胖受试者以150mg/min的速率输注葡萄糖导致内脏葡萄糖输出减少75%,这与对照受试者中观察到的情况相当,但动脉胰岛素显著升高(100%-200%)。得出的结论是,在肥胖状态下:(a)尽管基础状态存在高胰岛素血症,但内脏对葡萄糖前体的摄取增加,糖异生对总葡萄糖释放的相对贡献比对照受试者高70%;(b)以导致动脉胰岛素等量增加的速率输注葡萄糖时,与对照受试者相比,内脏葡萄糖输出的抑制作用较小;(c)以内脏葡萄糖输出受到类似抑制的速率输注葡萄糖时,与对照受试者相比,内源性胰岛素的增加比例过大。这些数据与肥胖状态下肝脏对胰岛素的抵抗情况相符。